Name I think Eddingpharm is s fairly good example of one of Suda's main problems. Once the deal is done we lose complete control and I think it is entirely possible nothing has been mentioned about Eddingpharm because they simply don't know.
I hope I am wrong but after two years one would think they would have or should have a fairly concrete idea of where things are at and so the coming update will be interesting on this deal
Clyde
SUD Price at posting:
0.6¢ Sentiment: Hold Disclosure: Held